biohaven: "rimegepant pivotal phase 3 trial results -- conference call.".

experts say years of cuts to nhs budgets and staff has led to patients waiting longer for ­chemotherapy and radiotherapy.. march 2018  (23)..

he said: "our research shows that people, on average, believe that only 34 per cent of protection claims are paid out by insurance companies...